Long Term Extension Trial of Setmelanotide

Clinical trial NCT03651765 · COMPLETED

Trial details

NCT number: NCT03651765
Sponsor: Rhythm Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Obesity Associated With Defects in Leptin-melanocortin Pathway

Start date: 2018-07-15
Primary completion: 2025-01-09
Enrollment: 205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.